View in EDS HTML Full Text PDF Full Text

Upfront use of eculizumab to treat early acute antibody‐mediated rejection after kidney allotransplantation and relevance for xenotransplantation.

Saved in:
Bibliographic Details
Title: Upfront use of eculizumab to treat early acute antibody‐mediated rejection after kidney allotransplantation and relevance for xenotransplantation.
Authors: Schwotzer, Nora1 (AUTHOR), Paganetti, Giulia1 (AUTHOR), Barchi, Matteo1 (AUTHOR), Perrottet, Nancy2 (AUTHOR), Aubert, Vincent3 (AUTHOR), Sadallah, Salima3 (AUTHOR), Rotman, Samuel4 (AUTHOR), Venetz, Jean‐Pierre1 (AUTHOR), Matter, Maurice5 (AUTHOR), Golshayan, Dela1 (AUTHOR), Pascual, Manuel1 (AUTHOR) manuel.pascual@chuv.ch
Source: Xenotransplantation. Jul2020, Vol. 27 Issue 4, p1-5. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:0908665X
DOI:10.1111/xen.12630